[go: up one dir, main page]

TR200200224T2 - Böbrek bozukluğu ve hastalıklarının önlenmesi ve tedavisi için bileşim - Google Patents

Böbrek bozukluğu ve hastalıklarının önlenmesi ve tedavisi için bileşim

Info

Publication number
TR200200224T2
TR200200224T2 TR2002/00224T TR200200224T TR200200224T2 TR 200200224 T2 TR200200224 T2 TR 200200224T2 TR 2002/00224 T TR2002/00224 T TR 2002/00224T TR 200200224 T TR200200224 T TR 200200224T TR 200200224 T2 TR200200224 T2 TR 200200224T2
Authority
TR
Turkey
Prior art keywords
prevention
treatment
composition
diseases
kidney disorders
Prior art date
Application number
TR2002/00224T
Other languages
English (en)
Inventor
Cavazza Cluadio
Original Assignee
Sigma-Tau Healtscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healtscience S.P.A. filed Critical Sigma-Tau Healtscience S.P.A.
Publication of TR200200224T2 publication Critical patent/TR200200224T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Böbrek islev bozuluklari ve böbrek hastaliklarinin önlenmesi ve tedavisi için uygun olan ve bu nedenle bir gida ilavesi veya gerçek bir medikal ilaç formunda olabilen, asetil L-karnitin ve propiyonil L-karnitin veya bunlarin farmakolojik olarak kabul edilebilir tuzlarini içeren bir bilesim açiklanmaktadir.
TR2002/00224T 1999-07-28 2000-07-25 Böbrek bozukluğu ve hastalıklarının önlenmesi ve tedavisi için bileşim TR200200224T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000483A IT1306179B1 (it) 1999-07-28 1999-07-28 Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.

Publications (1)

Publication Number Publication Date
TR200200224T2 true TR200200224T2 (tr) 2002-08-21

Family

ID=11406910

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00224T TR200200224T2 (tr) 1999-07-28 2000-07-25 Böbrek bozukluğu ve hastalıklarının önlenmesi ve tedavisi için bileşim

Country Status (20)

Country Link
US (2) US6653349B1 (tr)
EP (1) EP1200077B1 (tr)
AR (1) AR024981A1 (tr)
AT (1) ATE314064T1 (tr)
AU (1) AU779094B2 (tr)
CA (1) CA2378724C (tr)
CZ (1) CZ20024A3 (tr)
DE (1) DE60025215T2 (tr)
DK (1) DK1200077T3 (tr)
ES (1) ES2254206T3 (tr)
HU (1) HU229185B1 (tr)
IL (1) IL147410A0 (tr)
IT (1) IT1306179B1 (tr)
MX (1) MXPA02000911A (tr)
NO (1) NO20020369L (tr)
PL (1) PL208961B1 (tr)
SK (1) SK952002A3 (tr)
TN (1) TNSN00163A1 (tr)
TR (1) TR200200224T2 (tr)
WO (1) WO2001007039A2 (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011977B2 (en) * 1999-01-30 2006-03-14 Sigma-Tau Pharmaceuticals, Inc. Quantification of carnitine levels in dialysis patients
US7238531B2 (en) * 1999-01-30 2007-07-03 Pediatrix Screening, Inc. Method for interpreting tandem mass spectrometry data for clinical diagnosis
US7297545B2 (en) * 1999-01-30 2007-11-20 Pediatrix Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry and internal standards therefor
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
US7709539B2 (en) * 2004-08-11 2010-05-04 Chang Gung University Therapeutic use of resveratrol for hyperglycemia
US20060153934A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and magnesium
AU2006279429B2 (en) 2005-08-17 2010-02-25 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of kidney disease
ES2385169B1 (es) * 2010-12-22 2013-09-23 Servicio Andaluz De Salud Uso de la l-carnitina y sus composiciones, para el tratamiento y la prevención del daño renal.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246835A (en) * 1991-05-24 1993-09-21 Wakamoto Pharmaceutical Co., Ltd. Method of diagnosing renal diseases
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.
IT1291113B1 (it) 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1295408B1 (it) * 1997-10-03 1999-05-12 Sigma Tau Ind Farmaceuti Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.

Also Published As

Publication number Publication date
DE60025215D1 (de) 2006-02-02
HUP0202314A2 (en) 2002-10-28
NO20020369L (no) 2002-03-21
TNSN00163A1 (fr) 2005-11-10
EP1200077B1 (en) 2005-12-28
ATE314064T1 (de) 2006-01-15
CA2378724C (en) 2008-10-14
DE60025215T2 (de) 2006-07-13
AU779094B2 (en) 2005-01-06
SK952002A3 (en) 2002-06-04
US20040057994A1 (en) 2004-03-25
US6653349B1 (en) 2003-11-25
IT1306179B1 (it) 2001-05-30
US7585896B2 (en) 2009-09-08
WO2001007039A2 (en) 2001-02-01
ES2254206T3 (es) 2006-06-16
WO2001007039A3 (en) 2001-03-29
HUP0202314A3 (en) 2003-03-28
CA2378724A1 (en) 2001-02-01
PL354412A1 (en) 2004-01-12
EP1200077A2 (en) 2002-05-02
ITRM990483A1 (it) 2001-01-28
HU229185B1 (en) 2013-09-30
IL147410A0 (en) 2002-08-14
ITRM990483A0 (it) 1999-07-28
NO20020369D0 (no) 2002-01-23
DK1200077T3 (da) 2006-04-24
AR024981A1 (es) 2002-11-06
PL208961B1 (pl) 2011-06-30
AU6469200A (en) 2001-02-13
MXPA02000911A (es) 2002-10-23
CZ20024A3 (cs) 2002-06-12

Similar Documents

Publication Publication Date Title
FI3457135T3 (fi) Fabryn taudin hoitovaihtoehtoja
DE50107844D1 (de) Curcumin-derivate mit gegenüber curcumin verbesserter wasserlöslichkeit und diese enthaltende arzneimittel
IL178072A (en) Use of monoesters of probucol or a pharmaceutically acceptable salt thereof for preparing medicaments for the treatment of cardiovascular and inflammatory disease
NZ543661A (en) Pyrazolo-quinazoline derivatives having antitumor activity and process for their preparation
NZ709704A (en) Protein formulations and methods of making same
ZA200802811B (en) Therapy for the treatment of disease
PT998287E (pt) Utilizacao de levobupivacaina
EP1952809A3 (en) Formulations for the reduction of breast density with 4-Hydroxy Tamoxifen
EP1992338A3 (en) Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
TR200200224T2 (tr) Böbrek bozukluğu ve hastalıklarının önlenmesi ve tedavisi için bileşim
EP1440690A3 (en) Treatment of neurotic disorders
JP2005511619A5 (tr)
CY1109051T1 (el) Χρηση καρνιτινων για την προληψη και/ή θεραπεια διαταραχων που προκαλουνται απο την ανδροπαυση
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
BR0309055A (pt) Uso combinado de l-carnitina, acetil l-carnitina e propionil l-carnitina para o tratamento da oligoastenoteratospermia
NO971453D0 (no) Anvendelse av bradykinin-antagonister for fremstilling av legemidler for behandling av kroniske fibrogenetiske og akutte leversykdommer
IT1306186B1 (it) Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale
ATE404519T1 (de) Hyperforinderivate, ihre verwendung sowie diese enthaltende zubereitungen
MXPA03010919A (es) Uso de acetil l-carnitina para preparacion de medicamento para terapia preventiva del dolor.
FR2864089B1 (fr) Derives carboxy-reduits de la chondroitine sulfate, leur preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
HUP0402118A3 (en) Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease
BR0202030A (pt) Produto á base de planta medicinal aplicado no combate à cólica renal, cálculos renais e afecções renais
RU98112366A (ru) Препарат для лечения зудящих заболеваний
RU2003135586A (ru) Способ лечения бактериальной дизентерии у детей
RU98112422A (ru) Способ торакопластики для лечения эмпием плевральной полости